Patient
SITE007-0033
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2025-09-29
Adverse events
9
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 9
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-05-09 (study day 30); relationship: not assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-05-06 (study day 27); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-05-04 (study day 25); relationship: not assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-05-01 (study day 22); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-04-29 (study day 20); relationship: RELATED
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-04-26 (study day 17); relationship: not assessed
Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-04-26 (study day 17); relationship: not assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-04-14 (study day 5); relationship: not assessed
Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-04-12 (study day 3); relationship: NOT RELATED; serious criteria: hospitalization
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.